Diabetic retinopathy - PowerPoint PPT Presentation

About This Presentation
Title:

Diabetic retinopathy

Description:

bleeh – PowerPoint PPT presentation

Number of Views:1
Slides: 53
Provided by: Mirajayne1512
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Diabetic retinopathy


1
DIABETIC RETINOPATHYDr. Annamary StanislausMD,
MMED
2
Applied Anatomy
  • Retina, the innermost tunic of the eyeball, is a
    thin, delicate and transparent membrane.
  • It is the most highly-developed tissue of the
    eye.
  • It appears purplish-red due to the visual purple
    of the rods and underlying vascular choroid.

3
  • Retina extends from the optic disc to the ora
    serrata.
  • Grossly it is divided into two distinct regions
  • posterior pole and peripheral retina separated by
    the so called retinal equator.
  • Retinal equator is an imaginary line which is
    considered to lie in line with the exit of the
    four vena verticose.

4
  • Posterior pole refers to the area of the retina
    posterior to the retinal equator.
  • The posterior pole of the retina includes two
    distinct areas the optic disc and macula lutea
  • Posterior pole of the retina is best examined by
    slit-lamp indirect biomicroscopy using 78D and
    90D lens and direct ophthalmoscopy

5
(No Transcript)
6
(No Transcript)
7
Anatomy cont.
  • Microscopic structure
  • Retina consists of 3 types of cells and their
    synapses
  • arranged (from without inward) in the following
    ten
  • layers

8
Photoreceptors
  • Rods and Cones
  • Rods and cones are the end organs of vision and
    are also known as photoreceptors.
  • There are about 120 millions rods and 6.5
    millions cones.
  • Rods contain a photosensitive substance visual
    purple (rhodopsin) and subserve the peripheral
    vision and vision of low illumination (scotopic
    vision).
  • Cones also contain a photosensitive substance and
    are primarily responsible for highly
    discriminatory central vision (photopic vision)
    and colour vision.

9
Diabetic Retinopathy
  • Epidemiology
  • RISK of developing DR
  • Type I or IDDM 70
  • Type II or NIDDM - 39
  • Type II on insulin 70

10
  • Prevalence of the type of Diabetes
  • Type 2 in 90 of diabetic patients
  • Diabetic retinopathy - most common cause of legal
    blindness between ages 20 and 70 years.

11
RISK FACTORS
  • Duration of diabetes
  • Poor control of Diabetes
  • Hypertension
  • Nephropathy
  • Obesity and hyperlipidemia
  • Smoking
  • Pregnancy

12
Pathogenesis
  • Microangiopathy which has features of both
    microvascular leakage and occlusion
  • Larger vessels may also be involved

13
Microvascular leakage
  • Loss of pericytes results in distention of weak
    capillary wall producing microaneurysms which
    leak.
  • Blood-retinal barrier breaks down causing plasma
    constituents to leak into the retina retinal
    oedema, hard exudates

14
Microvascular occlusion
  • Basement membrane thickening, endothelial cell
    damage, deformed RBCs, platelet stickiness and
    aggregation
  • Vascular Endothelial Growth Factor (VEGF) is
    produced by hypoxic retina
  • VEGF stimulates the growth of shunt and new
    vessels

15
Classification of DR
  • I. Non-proliferative DR (NPDR)
  • Mild
  • Moderate
  • Severe
  • Very severe
  • Proliferative DR (PDR)
  • III. Clinically significant macular oedema (CSME)
  • - May exist by itself or along with NPDR
    and PDR

16

Mild NPDR
  • At least one microaneurysm - earliest clinically
    detectable lesion
  • Retinal hemorrhages
  • Hard or soft exudates

17
Moderate NPDR
  • Microaneurysms and/or dot and blot hemorrhages in
    at least 1 quadrant
  • Soft exudates (Cotton wool spots)
  • Venous beading or IRMA (intraretinal
    microvascular abnormalities)

IRMA
18
Mild and Moderate Non- proliferative DR was
previously known as Background DR
19
Severe NPDR
  • Any one of the following 3 features is present
  • Microaneurysms and intraretinal hemorrhages in
    all 4 quadrants
  • Venous beading in 2 or more quadrants
  • Moderate IRMA in at least 1 quadrant
  • Known as the 4-2-1 rule

20
Very severe NPDR
  • Any two of the features of the 4-2-1 rule is
    present

21
Severe and Very severe Non-proliferative DR was
known as the Pre-proliferative DR
22
Clinically significant Macular Oedema
  • Retinal oedema close to fovea
  • Hard exudates close to fovea
  • Presents with dimness of vision
  • By itself or along with NPDR or PDR

23
CSME Hard exudates close to fovea and
associated retinal thickening
24
Proliferative DR (PDR)
  • Characterized by Proliferation of new vessels
    from retinal veins
  • New vessels on the optic disc
  • New vessels elsewhere on the retina

25
Proliferative DR
NVD
26
COMPLICATIONS OF DIABETIC RETINOPATHY
  • Vitreous hemorrhage
  • Tractional retinal detachment
  • Rubeosis Iridis
  • Glaucoma
  • Blindness

27
Vitreous Hemorrhage
SUBHYALOID HEMORRHAGE
28
Tractional retinal detachment
29
Rubeosis Iridis
30
Neovascular Glaucoma
  • Complication of rubeosis iridis
  • New vessels cause angle closure
  • Mechanical obstruction to aqueous outflow
  • Intra ocular pressure rises
  • Pupil gets distorted as iris gets pulled
  • Eye becomes painful and red
  • Loss of vision

31
Blindness
  • Non-clearing vitreous hemorrhage
  • Neovascular glaucoma
  • Tractional retinal detachment
  • Macular ischemia

32
PREVENTION OF COMPLICATIONS
  • By early institution of appropriate treatment
  • This requires early detection of DR in its
  • asymptomatic treatable condition
  • By routine fundus examination of all Diabetics
    (cost effective screening)
  • And appropriate referral to ophthalmologist

33
Mild and Moderate NPDR
  • - No specific treatment for retinopathy
  • Good metabolic control to delay progression
  • Control of associated Hypertension, Anemia and
    Renal failure
  • Severe and very severe NPDR
  • Close follow up by Ophthalmologist

34
Clinically significant macular oedema
  • Laser photocoagulation to minimise risk of visual
    loss
  • Proliferative DR
  • Retinal laser photocoagulation as per the
    judgment of ophthalmologist (in high risk eyes)
  • It converts hypoxic retina (which produces
    ANGIOGENIC factors) into anoxic retina (which
    cant)

35
Screening protocol for Diabetic retinopathy
  • Screening once in a 1 year
  • Diabetics with normal fundus
  • Mild NPDR
  • Screening once in 6 months
  • Moderate NPDR

36
Referral to Ophthalmologist
  • Visual Symptoms
  • Diminished visual acuity
  • Seeing floaters
  • Painful eye
  • Fundus findings
  • - Macular oedema/hard exudates close to fovea
  • - Proliferative DR
  • - Vitreous hemorrhage
  • - Moderate to severe and very severe NPDR
  • Retinal detachment
  • Cataract obscuring fundus view

37
Referral to Ophthalmologist
  • Presence of Risk Factors
  • - Pregnancy
  • - Nephropathy

38
DIRECT OPHTHALMOSCOPY
  • Examination of the fundus of the eye
  • To screen for Diabetic Retinopathy
  • After dilatation of both eyes with 0.5
    tropicamide

39
View of the retina through an ophthalmoscope
40
Normal fundus views of Right and left eye
41
Mild NPDR Microaneurysms, Dot and Blot
hemorrhages
42
Moderate NPDR
43
Moderate NPDR with CSME
44
  • Severe NPDR
  • Cotton wool patches
  • Hemorrhages - 4 quadrants

With CSME
45
Very severe NPDR
  • Venous beading
  • scars of laser spots
  • Absorbing hemorrhages

Cotton-wool patches, venous segmentation
46
CSME in Different Stages of NPDR
47
Proliferative DR New vessels elsewhere on the
retina along the supero-temporal vessels
48
PDR New vessels on disc
49
PDR New vessels on disc and new vessels
elsewhere on retina
50
PDR with vitreous hemorrhage
Vitreous bleed
51
Vitreous Hemorrhage
52
Thank you!
Write a Comment
User Comments (0)
About PowerShow.com